Initial comparison of recruited individuals revealed significantly higher CA19.9 and C-reactive protein (CRP) levels in patients with pancreatic adenocarcinoma when compared to healthy controls (presented in Table 1). Here, CRP is linked to pancreatic adenocarcinoma.